A new in vitro diagnostic test for prostate cancer may be on the way to replacing the traditional PSA test and perhaps some biopsy procedures. The test is known as EXO106, which focuses on identifying the novel 4 gene prostate cancer signature. Exosomes are substances within human cells carrying nucleic acids which are unique to specific diseases. By testing blood or urine, it can be determined if an exosome related to a specific disease is present. In addition, EXO106 may also be able to predict the severity of prostate cancer and how well the prostate cancer is responding to treatment.
Thank you for visiting UroSciences, makers of the UroStop device for preventing climacturia or urine leakage during sex after radical prostatectomy (prostate surgery).